Christopher Ray Aker - Net Worth and Insider Trading

Christopher Ray Aker Net Worth

The estimated net worth of Christopher Ray Aker is at least $14,782 dollars as of 2024-11-05. Christopher Ray Aker is the Sr. VP & General Counsel of Regulus Therapeutics Inc and owns about 10,056 shares of Regulus Therapeutics Inc (RGLS) stock worth over $14,782. Details can be seen in Christopher Ray Aker's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher Ray Aker has not made any transactions after 2024-01-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Christopher Ray Aker

To

Christopher Ray Aker Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher Ray Aker owns 1 companies in total, including Regulus Therapeutics Inc (RGLS) .

Click here to see the complete history of Christopher Ray Aker’s form 4 insider trades.

Insider Ownership Summary of Christopher Ray Aker

Ticker Comapny Transaction Date Type of Owner
RGLS Regulus Therapeutics Inc 2024-01-18 Sr. VP & General Counsel

Christopher Ray Aker Latest Holdings Summary

Christopher Ray Aker currently owns a total of 1 stock. Christopher Ray Aker owns 10,056 shares of Regulus Therapeutics Inc (RGLS) as of January 18, 2024, with a value of $14,782.

Latest Holdings of Christopher Ray Aker

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RGLS Regulus Therapeutics Inc 2024-01-18 10,056 1.47 14,782

Holding Weightings of Christopher Ray Aker


Christopher Ray Aker Form 4 Trading Tracker

According to the SEC Form 4 filings, Christopher Ray Aker has made a total of 7 transactions in Regulus Therapeutics Inc (RGLS) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Regulus Therapeutics Inc is the sale of 5,468 shares on January 18, 2024, which brought Christopher Ray Aker around $6,507.

Insider Trading History of Christopher Ray Aker

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Christopher Ray Aker Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Christopher Ray Aker Ownership Network

Ownership Network List of Christopher Ray Aker

No Data

Ownership Network Relation of Christopher Ray Aker

Insider Network Chart

Christopher Ray Aker Owned Company Details

What does Regulus Therapeutics Inc do?

Who are the key executives at Regulus Therapeutics Inc?

Christopher Ray Aker is the Sr. VP & General Counsel of Regulus Therapeutics Inc. Other key executives at Regulus Therapeutics Inc include Chief Financial Officer Crispina Calsada , Chief Operating Officer Joseph P Hagan , and President & Head of R & D Preston Klassen .

Regulus Therapeutics Inc (RGLS) Insider Trades Summary

Over the past 18 months, Christopher Ray Aker made 1 insider transaction in Regulus Therapeutics Inc (RGLS) with a net sale of 5,468. Other recent insider transactions involving Regulus Therapeutics Inc (RGLS) include a net sale of 14,580 shares made by Joseph P Hagan , a net sale of 5,468 shares made by Crispina Calsada , and a net purchase of 4,000 shares made by Kathryn J Collier .

In summary, during the past 3 months, insiders sold 0 shares of Regulus Therapeutics Inc (RGLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 25,516 shares of Regulus Therapeutics Inc (RGLS) were sold and 4,000 shares were bought by its insiders, resulting in a net sale of 21,516 shares.

Regulus Therapeutics Inc (RGLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Regulus Therapeutics Inc Insider Transactions

No Available Data

Christopher Ray Aker Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher Ray Aker. You might contact Christopher Ray Aker via mailing address: C/o Regulus Therapeutics Inc., 10614 Science Center Drive, San Diego Ca 92121.